Back to News
Feb 11, 2026 12:02 PM

Humana Hits 52-Week Low After Weak Profit Outlook

Humana Inc. (NYSE:HUM) stock tumbled to a fresh 52-week low on Wednesday after the health insurer’s fiscal 2026 outlook fell well short of Wall Street expectations, overshadowing a fourth-quarter revenue beat and solid operating performance.

Outlook

Humana expects fiscal 2026 adjusted earnings per share of at least $9, compared to the Wall Street estimate of $11.92.

The anticipated year-over-year decline from $9.84 in 2025 is driven by the Star Ratings headwind for Bonus Year 2026, net of mitigation.

The company expects the 2026 Insurance segment benefit ratio to be 92.75%, plus or minus 25 basis points, with an operating cost ratio of 10%.

Humana anticipates fiscal 2026 individual Medicare Advantage membership growth of approximately 25% over 2025, driven by new sales and improved retention from the company’s customer-led benefit strategy and changes to its customer service approach.

The company expects Group Medicare Advantage growth of approximately 150,000 and Individual Medicare stand-alone PDP growth of ...